PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Program for Cell Enhancement and Technologies for Immunotherapy, Children\'s National Medical Center, Washington, DC, USA.\', \'Institute for Biomedical Sciences, George Washington University, Washington, DC, USA.\', \'National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA.\', \'National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.\', \'Program for Cell Enhancement and Technologies for Immunotherapy, Children\'s National Medical Center, Washington, DC, USA. Electronic address: cbollard@childrensnational.org.\', \'Program for Cell Enhancement and Technologies for Immunotherapy, Children\'s National Medical Center, Washington, DC, USA. Electronic address: ccruz@childrensnational.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1465-3249(21)00741-610.1016/j.jcyt.2021.07.006
?:hasPublicationType
?:journal
  • Cytotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34483067
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.144
?:rankingScore_hIndex
  • 72
?:title
  • Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34483067>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34483067>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all